Resmed (RSMDF) EBIT (QoQ) (2009 - 2026)
Analysis
Resmed (RSMDF) EBIT (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 178.19 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.42 Bn | 119.20 Bn | 1.96 Bn |
| 3 | Medtronic | 118.24 Bn | 109.42 Bn | 6.34 Bn |
| 4 | Stryker | 105.02 Bn | 101.55 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.48 Bn | 65.94 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn |
| 8 | Dexcom | 32.34 Bn | 30.40 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.22% |
| Mar 31, 2026 | 1.66% |
| Dec 31, 2025 | 10.11% |
| Sep 30, 2025 | -1.76% |
| Jun 30, 2025 | 6.63% |
| Mar 31, 2025 | 2.16% |
| Dec 31, 2024 | 7.73% |
| Sep 30, 2024 | 1.60% |
| Jun 30, 2024 | 1.77% |
| Mar 31, 2024 | 36.17% |
| Dec 31, 2023 | -4.81% |
| Sep 30, 2023 | 4.99% |
| Jun 30, 2023 | -8.45% |
| Mar 31, 2023 | 7.31% |
| Dec 31, 2022 | 1.62% |
| Sep 30, 2022 | 7.96% |
| Jun 30, 2022 | 9.02% |
| Mar 31, 2022 | -5.81% |
| Dec 31, 2021 | -5.04% |
| Sep 30, 2021 | 8.39% |